Yogurt Consumption for Diet
(YOGBIO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Substantial evidence links yogurt consumption to a lower risk of type 2 diabetes (T2D). However, the existing evidence is derived exclusively from prospective cohort studies relying on self-reported dietary questionnaires, which-despite being validated-are subject to random and systematic errors that may compromise evidence quality and hinder regulatory approval.
The project aims to discover and validate biomarkers of yogurt intake.
The investigators will conduct a randomized, crossover, dose-response feeding trial involving 16 generally healthy adult participants (8 females, 8 males). The trial will include four 7-day diet periods, each separated by a 1-week washout. All diets will be based on a dairy-free background and supplemented with one of the following: (a) 1 serving of soy-based pudding (no yogurt), (b) 0.5 serving of yogurt, (c) 1 serving of yogurt, or (d) 2 servings of yogurt per 2,380 kcal/day.
On the 7th day of each diet, participants will complete a mixed-meal test at INAF, consuming a smoothie containing the same yogurt dose as during the preceding days. Plasma samples collected in the postprandial state will be used to profile over 20,000 metabolites. Using artificial intelligence-based approaches, potential biomarkers of yogurt intake will be identified. These candidates will then be filtered using standard statistical methods to assess dose- and time-responsiveness, robustness, and biological plausibility. Biomarkers that meet all criteria will be considered validated indicators of yogurt intake.
Who Is on the Research Team?
Jean-Philippe Drouin-Chartier, PhD
Principal Investigator
Laval University
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Diet Intervention
Participants undergo four 7-day diet periods with different yogurt servings, each separated by a 1-week washout period.
Follow-up
Participants are monitored for safety and effectiveness after the diet interventions.
What Are the Treatments Tested in This Trial?
Interventions
- Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
The trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 90 g per 2,380 kcal per day of yogurt (i.e., 0.5 reference serving of yogurt per 2,380 kcal per day).
The trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 350 g per 2,380 kcal per day of yogurt (2 reference servings per 2,380 kcal per day).
The trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the low yogurt-diet, the diet will include 175 g per 2,380 kcal per day of yogurt (1 reference serving of yogurt per 2,380 kcal per day).
The trial will consist of 4 predetermined diets, each lasting 7 days and separated by a 1-week washout period. The 4 diets will be based on a dairy-free background diet reflecting high adherence to Canada's food guide. In the yogurt-free control diet, the diet will include 125 g per 2,380 kcal per day of a soy-based pudding.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.